An observational study in Hematological Diseases and Critical Illness, sponsored by University Hospital A Coruña. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-02.
Sponsored by University Hospital A Coruña · Observational
Multicenter, observational and prospective study.
The data collection period will include 6 consecutive months, starting from the date of acceptance or conformity of the CEIC. Or, until an adequate sample size is reached that guarantees the statistical relevance of said analysis. All patients will subsequently be followed up 3 months after discharge from the ICU.
460 studies on the registry are indexed under Hematologic Diseases; 105 are open to participants now.
This study's planned enrollment of 800 is above the median of 228 across 129 observational studies indexed under Hematologic Diseases.
Browse Hematologic Diseases studies →University Hospital A Coruña is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with a diagnosis of solid organ or hematological tumor who are admitted to the hospital and require ICU evaluation.
Exclusion Criteria:
-under 18 years old
Other: There is no intervention.
Other: There is no intervention.
There is no intervention in the study.
Hospital mortality.
Time frame: During the 6 months of the study.
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital A Coruña